The low-density lipoprotein receptor (LDLR)-related protein 1 (LRP-1) belongs to the LDLR family, which includes LDLR, LRP-2/megalin, very lowdensity lipoprotein receptor and apolipoprotein E (apoE) receptor 2. Previous studies showed that these receptors have distinct physiological roles in various organs. LRP-1 was originally identified as an endocytic receptor for apoE and a2-macrogloblin; however, accumulated evidence showed that LRP-1 binds not only to these two molecules, but also to various ligands, such as lipoprotein lipase and tissue plasminogen activator. In addition, LRP-1 is now known to function not only as an endocytic receptor, but also as a mediator of cellular signal transduction 1 . LRP-1 is abundantly expressed in hepatocytes, adipocytes, vascular smooth muscle cells and neurons, all of which play a role in systemic metabolism and are closely associated with diabetic complications. The mode of action of LRP-1 clearly suggests its multiple physiological roles in various cells.
In hepatocytes, LRP-1 is known to mediate the endocytosis and degradation of chylomicron remnants, very low-density lipoprotein and so on. Indeed, the in vivo ablation of LRP-1 expression in hepatocytes results in decreased insulinmediated clearance of chylomicron remnants. In addition, mice in which LRP-1 is specifically deleted in the liver showed diet-induced insulin resistance with dyslipidemia and hepatic steatosis, probably as a result of increased hepatic lipogenesis and reduced very low-density lipoprotein secretion. These mice also showed reduced expression of insulin receptors (IRs) on the surface of hepatocytes, as well as decreased glucose transporter 2 translocation. These data suggest that cell surface expression of IRs in hepatocytes seems to be LRP-1 dependent, and that LRP-1 plays an essential role in IR signaling in the liver 2 . LRP-1 is also highly expressed in adipocytes. Considering that LRP-1 mediates the endocytosis and degradation of lipoproteins in hepatocytes, it is not difficult to imagine that LRP-1 in adipocytes plays an important role in lipid accumulation in adipocytes. Indeed, mice in which LRP-1 was specifically inactivated in adipose tissues showed delayed postprandial lipid clearance, reduced bodyweight with smaller fat stores and elevated energy expenditure with lipiddepleted brown adipocytes. These findings show that LRP-1 plays a critical role in adipocyte energy homeostasis. Reduced lipid accumulation in brown adipocytes was shown to result in a shift from fat to muscle tissues for body core temperature maintenance 3 . In contrast, LRP-1 is known to be expressed in glucose transporter (GLUT4)-containing vesicles and to be essential for insulindependent glucose transport through GLUT4 translocation from the cytosol to the cell surface in adipocytes. Indeed, LRP-1-depleted adipocytes showed reduced GLUT4 expression and decreased insulin-stimulated glucose uptake 4 . In addition to these roles of LRP-1 in lipid and glucose metabolism in the liver and adipocytes, Ye et al. 5 very recently showed a previously unidentified role of LRP-1 in pancreatic b-cells. This group first became interested in LRP-1 because they found that its expression in pancreatic islets was positively associated with plasma glucose levels and negatively associated with insulin levels in ob/ob mice. Thus, to investigate the causal relationship between decreased islet expression of LRP-1 and decreased b-cell function, they generated b-cells specific LRP-1 knockout (LRP-1-bKO) mice, in which doxycycline was used to specifically knock out LRP-1 in pancreatic b-cells. Under a high-fat diet, LRP-1-bKO mice showed deterioration of glucose tolerance as a result of decreased insulin levels. In addition, these mice showed an insufficient increase in b-cell volume and a decreased b-cell proliferation rate under the high-fat diet. Next, Ye et al. . Thus, the decrease in IRS2 expression by LRP-1 deletion seems to be an upstream defect in the insufficient increase in b-cell volume in LRP-1-bKO mice. Furthermore, regarding the cause of decreased IRS2 expression by LRP-1 deletion, extracellular regulated mitogenactivated protein kinase (Erk) and ribosomal protein S6 kinase (S6K1) were activated in the islets of LRP-1-bKO mice receiving the high-fat diet. Given the fact that Erk activates S6K1 and that S6K1 reduces the expression of IRS-2, Erk activation by LRP-1 deletion might be an additional upstream factor that decreases insulin signaling in b-cells. Although reduced IR and GLUT4 expression were observed in LRP-1-deleted hepatocytes and adipocytes, respectively, reduced IRS-2 expression was observed in LRP-1-deleted b-cells. Taken together, this accumulated evidence suggests that LRP-1 deletion impairs insulin signaling by reducing the expression of key factors of insulin signaling in various tissues, but the responsible molecule in each tissue is variable.
LRP-1 plays an important role in lipoprotein endocytosis in hepatocytes and adipocytes. Therefore, the deletion of LRP-1 results in the alteration of the accumulation of lipids in both cell types. Regarding b-cells, exposure to high-fat levels is known to induce b-cell dysfunction, a phenomenon known as "b-cell lipotoxicity." Although the underlying mechanism has not yet been elucidated, several studies suggest that it involves the accumulation of ceramide in b-cells. Intriguingly, decreased ceramide levels have been shown in LRP-1-bKO, suggesting the mitigation of b-cell lipotoxicity.
In addition to its central role in organs and tissues involved in systemic metabolism, LRP-1 plays a key function in other tissues. For instance, LRP-1 is abundantly expressed in smooth muscle cells, and mice in which LRP-1 is specifically deleted in these cells develop aneurysms due to disruption of the elastic layer, proliferation of smooth muscle cells and marked susceptibility to cholesterolinduced atherosclerosis 7 . In addition, mice in which LRP-1 is specifically deleted in macrophages show susceptibility to cholesterol-induced atherosclerosis 8 . Finally, although LRP-1 regulates the apoE gene, a variation of which is the strongest genetic risk factor for Alzheimer's disease, accumulating evidence suggests that LRP-1 in neurons, microglia, astrocytes, vascular smooth muscle cells and pericytes in the brain regulates the metabolism of amyloid-b peptide both in the brain and the periphery 9 . In summary, LRP-1 was originally identified as an endocytic receptor for apoE and a2-macrogloblin. However, this molecule plays broader roles in the metabolism of glucose and lipids, and the diseases associated with diabetes mellitus (Figure 1 ). Of note, an important hepatokine, selenoprotein P, decreases muscle responsiveness to exercise though LRP-1 10 . As the LRP-1 signal transduction pathway seems to differ markedly among cell types, gaining a clear understanding of the mode of action of LRP-1 is difficult, but understanding this mechanism could provide useful information for new treatment strategies for diabetes and its complications.
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